Global Cas12 Nuclease 麻豆原创 Research Report 2024

Publication ID:

PB510246569

Publication Date:

October 30, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Cas12 nuclease is a type of RNA-guided enzyme derived from the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) system. It functions as a programmable endonuclease that can recognize and cleave double-stranded DNA at specific sites guided by a single RNA molecule, known as CRISPR RNA (crRNA). Cas12 is notable for its collateral cleavage activity, allowing it to cut nearby single-stranded DNA, making it useful for various applications in gene editing, diagnostics, and synthetic biology.
The global Cas12 Nuclease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Cas12 Nuclease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cas12 Nuclease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cas12 Nuclease include Integrated DNA Technologies, Synthego, Danaher, GenScript, Sigma-Aldrich, Signalchem, BPS Bioscience, New England Biolabs, Intact Genomics, Molecular Cloning Laboratories, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cas12 Nuclease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cas12 Nuclease.
The Cas12 Nuclease market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Cas12 Nuclease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cas12 Nuclease manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Integrated DNA Technologies
Synthego
Danaher
GenScript
Sigma-Aldrich
Signalchem
BPS Bioscience
New England Biolabs
Intact Genomics
Molecular Cloning Laboratories
Yeasen Biotechnology
Beyotime Biotech
Segment by Type
Cas12a
Cas12b
Other
Segment by Application
Academic & Research Institutes
Biopharmaceutical
Hospitals & Diagnostic Centers
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cas12 Nuclease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cas12 Nuclease in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.鈥�

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Cas12 Nuclease 麻豆原创 Overview
1.1 Product Definition
1.2 Cas12 Nuclease by Type
1.2.1 Global Cas12 Nuclease 麻豆原创 Value Comparison by Type (2024-2030)
1.2.2 Cas12a
1.2.3 Cas12b
1.2.4 Other
1.3 Cas12 Nuclease by Application
1.3.1 Global Cas12 Nuclease 麻豆原创 Value by Application (2024-2030)
1.3.2 Academic & Research Institutes
1.3.3 Biopharmaceutical
1.3.4 Hospitals & Diagnostic Centers
1.3.5 Other
1.4 Global Cas12 Nuclease 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Cas12 Nuclease Revenue 2019-2030
1.4.2 Global Cas12 Nuclease Sales 2019-2030
1.4.3 Global Cas12 Nuclease 麻豆原创 Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cas12 Nuclease 麻豆原创 Competition by Manufacturers
2.1 Global Cas12 Nuclease Sales 麻豆原创 Share by Manufacturers (2019-2024)
2.2 Global Cas12 Nuclease Revenue 麻豆原创 Share by Manufacturers (2019-2024)
2.3 Global Cas12 Nuclease Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Cas12 Nuclease, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cas12 Nuclease, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cas12 Nuclease, Product Type & Application
2.7 Global Key Manufacturers of Cas12 Nuclease, Date of Enter into This Industry
2.8 Global Cas12 Nuclease 麻豆原创 Competitive Situation and Trends
2.8.1 Global Cas12 Nuclease 麻豆原创 Concentration Rate
2.8.2 The Global 5 and 10 Largest Cas12 Nuclease Players 麻豆原创 Share by Revenue
2.8.3 Global Cas12 Nuclease 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cas12 Nuclease 麻豆原创 Scenario by Region
3.1 Global Cas12 Nuclease 麻豆原创 Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cas12 Nuclease Sales by Region: 2019-2030
3.2.1 Global Cas12 Nuclease Sales by Region: 2019-2024
3.2.2 Global Cas12 Nuclease Sales by Region: 2025-2030
3.3 Global Cas12 Nuclease Revenue by Region: 2019-2030
3.3.1 Global Cas12 Nuclease Revenue by Region: 2019-2024
3.3.2 Global Cas12 Nuclease Revenue by Region: 2025-2030
3.4 North America Cas12 Nuclease 麻豆原创 Facts & Figures by Country
3.4.1 North America Cas12 Nuclease 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cas12 Nuclease Sales by Country (2019-2030)
3.4.3 North America Cas12 Nuclease Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cas12 Nuclease 麻豆原创 Facts & Figures by Country
3.5.1 Europe Cas12 Nuclease 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cas12 Nuclease Sales by Country (2019-2030)
3.5.3 Europe Cas12 Nuclease Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cas12 Nuclease 麻豆原创 Facts & Figures by Region
3.6.1 Asia Pacific Cas12 Nuclease 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cas12 Nuclease Sales by Region (2019-2030)
3.6.3 Asia Pacific Cas12 Nuclease Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cas12 Nuclease 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Cas12 Nuclease 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cas12 Nuclease Sales by Country (2019-2030)
3.7.3 Latin America Cas12 Nuclease Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cas12 Nuclease 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Cas12 Nuclease 麻豆原创 Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cas12 Nuclease Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cas12 Nuclease Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cas12 Nuclease Sales by Type (2019-2030)
4.1.1 Global Cas12 Nuclease Sales by Type (2019-2024)
4.1.2 Global Cas12 Nuclease Sales by Type (2025-2030)
4.1.3 Global Cas12 Nuclease Sales 麻豆原创 Share by Type (2019-2030)
4.2 Global Cas12 Nuclease Revenue by Type (2019-2030)
4.2.1 Global Cas12 Nuclease Revenue by Type (2019-2024)
4.2.2 Global Cas12 Nuclease Revenue by Type (2025-2030)
4.2.3 Global Cas12 Nuclease Revenue 麻豆原创 Share by Type (2019-2030)
4.3 Global Cas12 Nuclease Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cas12 Nuclease Sales by Application (2019-2030)
5.1.1 Global Cas12 Nuclease Sales by Application (2019-2024)
5.1.2 Global Cas12 Nuclease Sales by Application (2025-2030)
5.1.3 Global Cas12 Nuclease Sales 麻豆原创 Share by Application (2019-2030)
5.2 Global Cas12 Nuclease Revenue by Application (2019-2030)
5.2.1 Global Cas12 Nuclease Revenue by Application (2019-2024)
5.2.2 Global Cas12 Nuclease Revenue by Application (2025-2030)
5.2.3 Global Cas12 Nuclease Revenue 麻豆原创 Share by Application (2019-2030)
5.3 Global Cas12 Nuclease Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Integrated DNA Technologies
6.1.1 Integrated DNA Technologies Company Information
6.1.2 Integrated DNA Technologies Description and Business Overview
6.1.3 Integrated DNA Technologies Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Integrated DNA Technologies Cas12 Nuclease Product Portfolio
6.1.5 Integrated DNA Technologies Recent Developments/Updates
6.2 Synthego
6.2.1 Synthego Company Information
6.2.2 Synthego Description and Business Overview
6.2.3 Synthego Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Synthego Cas12 Nuclease Product Portfolio
6.2.5 Synthego Recent Developments/Updates
6.3 Danaher
6.3.1 Danaher Company Information
6.3.2 Danaher Description and Business Overview
6.3.3 Danaher Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Danaher Cas12 Nuclease Product Portfolio
6.3.5 Danaher Recent Developments/Updates
6.4 GenScript
6.4.1 GenScript Company Information
6.4.2 GenScript Description and Business Overview
6.4.3 GenScript Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GenScript Cas12 Nuclease Product Portfolio
6.4.5 GenScript Recent Developments/Updates
6.5 Sigma-Aldrich
6.5.1 Sigma-Aldrich Company Information
6.5.2 Sigma-Aldrich Description and Business Overview
6.5.3 Sigma-Aldrich Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sigma-Aldrich Cas12 Nuclease Product Portfolio
6.5.5 Sigma-Aldrich Recent Developments/Updates
6.6 Signalchem
6.6.1 Signalchem Company Information
6.6.2 Signalchem Description and Business Overview
6.6.3 Signalchem Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Signalchem Cas12 Nuclease Product Portfolio
6.6.5 Signalchem Recent Developments/Updates
6.7 BPS Bioscience
6.7.1 BPS Bioscience Company Information
6.7.2 BPS Bioscience Description and Business Overview
6.7.3 BPS Bioscience Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.7.4 BPS Bioscience Cas12 Nuclease Product Portfolio
6.7.5 BPS Bioscience Recent Developments/Updates
6.8 New England Biolabs
6.8.1 New England Biolabs Company Information
6.8.2 New England Biolabs Description and Business Overview
6.8.3 New England Biolabs Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.8.4 New England Biolabs Cas12 Nuclease Product Portfolio
6.8.5 New England Biolabs Recent Developments/Updates
6.9 Intact Genomics
6.9.1 Intact Genomics Company Information
6.9.2 Intact Genomics Description and Business Overview
6.9.3 Intact Genomics Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Intact Genomics Cas12 Nuclease Product Portfolio
6.9.5 Intact Genomics Recent Developments/Updates
6.10 Molecular Cloning Laboratories
6.10.1 Molecular Cloning Laboratories Company Information
6.10.2 Molecular Cloning Laboratories Description and Business Overview
6.10.3 Molecular Cloning Laboratories Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Molecular Cloning Laboratories Cas12 Nuclease Product Portfolio
6.10.5 Molecular Cloning Laboratories Recent Developments/Updates
6.11 Yeasen Biotechnology
6.11.1 Yeasen Biotechnology Company Information
6.11.2 Yeasen Biotechnology Description and Business Overview
6.11.3 Yeasen Biotechnology Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Yeasen Biotechnology Cas12 Nuclease Product Portfolio
6.11.5 Yeasen Biotechnology Recent Developments/Updates
6.12 Beyotime Biotech
6.12.1 Beyotime Biotech Company Information
6.12.2 Beyotime Biotech Description and Business Overview
6.12.3 Beyotime Biotech Cas12 Nuclease Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Beyotime Biotech Cas12 Nuclease Product Portfolio
6.12.5 Beyotime Biotech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cas12 Nuclease Industry Chain Analysis
7.2 Cas12 Nuclease Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cas12 Nuclease Production Mode & Process
7.4 Cas12 Nuclease Sales and 麻豆原创ing
7.4.1 Cas12 Nuclease Sales Channels
7.4.2 Cas12 Nuclease Distributors
7.5 Cas12 Nuclease Customers
8 Cas12 Nuclease 麻豆原创 Dynamics
8.1 Cas12 Nuclease Industry Trends
8.2 Cas12 Nuclease 麻豆原创 Drivers
8.3 Cas12 Nuclease 麻豆原创 Challenges
8.4 Cas12 Nuclease 麻豆原创 Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Integrated DNA Technologies
Synthego
Danaher
GenScript
Sigma-Aldrich
Signalchem
BPS Bioscience
New England Biolabs
Intact Genomics
Molecular Cloning Laboratories
Yeasen Biotechnology
Beyotime Biotech

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.